Search Within

Melissa Shaji Varghese

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
  3. Review (1)
Groups
  1. Epidemiology and Biostatistics (9)
  2. Radiation Oncology, Department of (9)
  3. Biostatistics Service (8)
  4. GDMT, Radiation Oncology (8)
  5. Gynecology Disease Management Team (8)
  6. Survivorship Research (8)

More Groups

People
  1. Marisa Kollmeier (8)
  2. Michael Zelefsky (8)
  3. Sean McBride (8)
  4. Zhigang Zhang (8)
  5. Daniel Gorovets (6)
  6. Debra Goldman (4)

More People

Years
  1. 2020 (4)
  2. 2019 (4)
  3. 2018 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Advances in Radiation Oncology (1)
  3. European Urology Oncology (1)
  4. Journal of Urology (1)
  5. Nature Reviews Urology (1)
  6. Radiotherapy and Oncology (1)
Publishers
  1. Elsevier Inc. (6)
  2. Elsevier BV (1)
  3. Elsevier Science, Inc. (1)
  4. Nature Publishing Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early tolerance and tumor control outcomes with high-dose ultrahypofractionated radiation therapy for prostate cancer
    Journal Article

    Zelefsky, M. J.; Pinitpatcharalert, A.; Kollmeier, M.; Goldman, D. A.; McBride, S.; Gorovets, D.; Zhang, Z.; Varghese, M.; Happersett, L.; Tyagi, N.; more...
    European Urology Oncology (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of combined prostate- and metastasis-directed radiation therapy for the treatment of de novo oligometastatic prostate cancer
    Journal Article

    Imber, B. S.; Varghese, M.; Goldman, D. A.; Zhang, Z.; Gewanter, R.; Marciscano, A. E.; Mychalczak, B.; Gorovets, D.; Kollmeier, M.; McBride, S. M.; more...
    Advances in Radiation Oncology (2020)

    Fulltext@MSK | Save
  • Low-dose-rate brachytherapy combined with ultrahypofractionated radiation therapy for clinically localized, intermediate-risk prostate cancer: Results from a prospective trial
    Journal Article

    Kollmeier, M. A.; McBride, S.; Varghese, M.; Debonis, D.; Zhang, Z.; Cohen, G.; Damato, A. L.; Mychalczak, B.; Gewanter, R.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Financial toxicity associated with treatment of localized prostate cancer
    Review

    Imber, B. S.; Varghese, M.; Ehdaie, B.; Gorovets, D.
    Nature Reviews Urology (2020)

    Fulltext@MSK | Save
  • Predictors of sexual function outcome after stereotactic body radiotherapy for localized prostate cancer
    Meeting Abstract

    Haseltine, J.; Happersett, L.; Flynn, J.; Kollmeier, M. A.; McBride, S.; Gorovets, D. Jr; Zhang, Z.; Mulhall, J.; Varghese, M.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Early biochemical predictors of survival in intermediate and high-risk prostate cancer treated with radiation and androgen deprivation therapy
    Journal Article

    Patel, M. A.; Kollmeier, M.; McBride, S.; Gorovets, D.; Varghese, M.; Chan, L.; Knezevic, A.; Zhang, Z.; Zelefsky, M. J.
    Radiotherapy and Oncology (2019)

    Fulltext@MSK | Save
  • Long-term implications of a positive posttreatment biopsy in patients treated with external beam radiotherapy for clinically localized prostate cancer
    Journal Article

    Zelefsky, M. J.; Goldman, D. A.; Reuter, V.; Kollmeier, M.; McBride, S.; Zhang, Z.; Varghese, M.; Pei, X.; Fuks, Z.
    Journal of Urology (2019)

    Fulltext@MSK | Save
  • Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer
    Journal Article

    Zelefsky, M. J.; Kollmeier, M.; McBride, S.; Varghese, M.; Mychalczak, B.; Gewanter, R.; Garg, M. K.; Happersett, L.; Goldman, D. A.; Pei, I.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • The first prostate specific antigen value after androgen deprivation therapy initiation and after definitive radiation therapy completion as a biomarker for disease relapse and mortality in intermediate and high risk prostate cancer
    Meeting Abstract

    Patel, M. A.; Kollmeier, M. A.; McBride, S.; Gorovets, D.; Varghese, M.; Knezevic, A.; Zhigang, Z.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save